Literature DB >> 20009527

Exploring the immunome: A brave new world for human vaccine development.

Anne S De Groot1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20009527      PMCID： PMC2919815          DOI： 10.4161/hv.10683

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN： 1554-8600


× No keyword cloud information.
  12 in total

1.  Development of a malaria T-cell vaccine for blood stage immunity.

Authors:  I A Quakyi; D W Taylor; A H Johnson; J B Allotey; J A Berzofsky; L H Miller; M F Good
Journal:  Scand J Immunol Suppl       Date:  1992

2.  New tools, new approaches and new ideas for vaccine development.

Authors:  Anne S De Groot; Leonard Moise
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

3.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

Review 4.  Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics.

Authors:  Anne S De Groot; William Martin
Journal:  Clin Immunol       Date:  2009-03-06       Impact factor: 3.969

5.  Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes.

Authors:  J McMurry; H Sbai; M L Gennaro; E J Carter; W Martin; A S De Groot
Journal:  Tuberculosis (Edinb)       Date:  2004-12-25       Impact factor: 3.131

6.  The measles campaign in West and Central Africa: remembering the future.

Authors:  Annie De Groot; Sory Ibrahima Bamba; Flabou Bougoudogo
Journal:  Vaccine       Date:  2008-06-02       Impact factor: 3.641

7.  Epitope-based vaccination against pneumonic tularemia.

Authors:  Stephen H Gregory; Stephanie Mott; Jennifer Phung; Jinhee Lee; Leonard Moise; Julie A McMurry; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

8.  C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.

Authors:  P W Dempsey; M E Allison; S Akkaraju; C C Goodnow; D T Fearon
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

9.  Evolutionary deimmunization: an ancillary mechanism for self-tolerance?

Authors:  Anne S De Groot; Miriam Goldberg; Leonard Moise; William Martin
Journal:  Cell Immunol       Date:  2007-04-18       Impact factor: 4.868

10.  Private specificities of CD8 T cell responses control patterns of heterologous immunity.

Authors:  Sung-Kwon Kim; Markus Cornberg; Xiaoting Z Wang; Hong D Chen; Liisa K Selin; Raymond M Welsh
Journal:  J Exp Med       Date:  2005-02-14       Impact factor: 14.307
View more
  3 in total

1.  Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.

Authors:  Beatriz Coutinho De Oliveira; Malcolm S Duthie; Valéria Rêgo Alves Pereira
Journal:  Hum Vaccin Immunother       Date:  2019-11-11       Impact factor: 3.452

2.  An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.

Authors:  Soraya Gaze; Patrick Driguez; Mark S Pearson; Tiago Mendes; Denise L Doolan; Angela Trieu; Donald P McManus; Geoffrey N Gobert; Maria Victoria Periago; Rodrigo Correa Oliveira; Fernanda C Cardoso; Guilherme Oliveira; Rie Nakajima; Al Jasinskas; Chris Hung; Li Liang; Jozelyn Pablo; Jeffrey M Bethony; Philip L Felgner; Alex Loukas
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

3.  Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.

Authors:  G Lizbeth Ramírez-Salinas; Jazmín García-Machorro; Saúl Rojas-Hernández; Rafael Campos-Rodríguez; Arturo Contis-Montes de Oca; Miguel Medina Gomez; Rocío Luciano; Mirko Zimic; José Correa-Basurto
Journal:  Arch Virol       Date:  2020-02-14       Impact factor: 2.574
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.